🇯🇵 Rovamycin in Japan

PMDA authorised Rovamycin on 2 July 2018

Marketing authorisation

PMDA — authorised 2 July 2018

  • Marketing authorisation holder: Sanofi KK
  • Status: approved

Rovamycin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in Japan

Frequently asked questions

Is Rovamycin approved in Japan?

Yes. PMDA authorised it on 2 July 2018.

Who is the marketing authorisation holder for Rovamycin in Japan?

Sanofi KK holds the Japanese marketing authorisation.